Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines

Author： Wagenblast Jens   Baghi Mehran   Arnoldner Christoph   Bisdas Sotirios   Gstöttner Wolfgang   Ackermann Hanns   May Angelika   Hambek Markus   Knecht Rainald  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.135, Iss.3, 2009-03, pp. : 387-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cetuximab in squamous cell carcinoma of the head and neck

By Hitt Ricardo   Martín Patricia   Hidalgo Manuel  

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 449-457

Future Medicine

Access to resources Recommend Favorite

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice

By Wang Yixiang  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 237-243

Springer Publishing Company

Access to resources Recommend Favorite

Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines

By            

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1326-1330

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2439-2445

Spandidos Publications

Access to resources Recommend Favorite

Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab

By                    

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 49-54

Spandidos Publications

Access to resources Recommend Favorite